Hypoxia-inducible expression of tumor-associated carbonic anhydrases

Cancer Research

Volumn 60, Issue 24, 2000, Pages 7075-7083

  Wykoff, Charles C ^a   Beasley, Nigel J P ^a   Watson, Peter H ^b   Turner, Kevin J ^a   Pastorek, Jaromir ^c   Sibtain, Amen ^d   Wilson, George D ^d   Turley, Helen ^a   Talks, Kate L ^a   Maxwell, Patrick H ^e   Pugh, Christopher W ^e   Ratcliffe, Peter J ^e   Harris, Adrian L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANITOBA   (Canada)

^c INSTITUTE OF VIROLOGY   (Slovakia)

^d MOUNT VERNON HOSPITAL   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; PIMONIDAZOLE; TUMOR PROTEIN; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPOXIA; KIDNEY CARCINOMA; NECROSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TUMOR CELL; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ANOXIA; BLOTTING, WESTERN; CARBONIC ANHYDRASES; CARCINOMA; CARCINOMA, RENAL CELL; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY NEOPLASMS; LYMPHOKINES; MODELS, GENETIC; NECROSIS; NITROIMIDAZOLES; NUCLEAR PROTEINS; OXYGEN; PLASMIDS; PROMOTER REGIONS (GENETICS); RADIATION-SENSITIZING AGENTS; RNA; RNA, MESSENGER; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034671307     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
2. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
3. Induction characteristics of oxygen regulated proteins
4. Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins
5. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
6. Candidate genes for the hypoxic tumor phenotype
7. Hypoxia inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
8. Role of HIF-lα in hypoxiamediated apoptosis, cell proliferation and tumour angiogenesis
9. HIF-1α is required for solid tumor formation and embryonic vascularization
10. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences
11. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor l
12. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
13. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
14. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase I: Involvement of HIF-1 in tumor progression
15. p53 inhibits hypoxia-inducible factor-stimulated transcription
16. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
17. Loss of PTEN facilitates HIF-1-mediated gene expression
18. Mutations of the VHL tumour suppressor gene in renal carcinoma
19. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity
20. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex
21. Hypoxia inducible factor-α binding and ubiquitination by the von Hippel-Lindau tumor suppressor protein
22. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit on serum withdrawal
23. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix
24. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment
25. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney
26. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation
27. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma
28. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers
29. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes
30. Human carbonic anhydrases and carbonic anhydrase deficiencies
31. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
32. A novel quasi-viral agent, Ma Tu, is a two-component system
33. The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: An in situ hybridization and immunocytochemical study
34. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays
35. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction
36. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1α subunit (HIF-1α)
37. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens
38. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships
39. Targeting gene expression to hypoxic tumour cells
40. The macrophage-a novel system to deliver gene therapy to pathological hypoxia
41. Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX. Identification and characterization of a proximal silencer element
42. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
43. p53 tumour suppressor modulates transcription of the TATA-less gene coding for the tumour-associated carbonic anhydrase MN/CA IX in MaTu cells
44. Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver
45. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime
46. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state
47. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis
48. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker
49. Are cancer cells acidic?
50. Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism
51. Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity
52. The contribution of lactic acid to acidification of tumours: Studies of variant cells lacking lactate dehydrogenase
53. Acidic pH enhances the invasive behavior of human melanoma cells
54. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
55. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies